Business Wire

The Work for Sustainability at Oulu University Hospital Brought Gold Medal in a Global Competition

Share

Oulu University Hospital's OYS 2030 -renewal program was ranked first in its category in the International Hospital Federation’s IHF Awards 2023 competition. The hospital participated in the Ashikaga-Nikken Excellence Award for Green Hospitals category, where hospitals and healthcare organizations promoting sustainable initiatives were recognized.

‘Winning in a high-level global competition is well-deserved recognition for all those who participated in building the new hospital. I am particularly grateful for the expertise provided by the staff and clients at the various stages of planning,’ says Miia Turpeinen, Director of the University Hospital.

Oulu University Hospital is one of Finland's five university hospitals. With its renewal program, a new hospital will be built in Oulu to serve Northern Finland as well as meet the needs of future specialized medical care.

Sustainability been taken into account in the renewal program, both during construction and in planning the future operations. Finland’s climate has been characterized by annual temperature changes. Situated near the Arctic Circle, temperatures in Oulu can range from a high of +32 degrees to a low of -35 degrees Celsius. The hospital's northern location and the changing weather conditions affect its planning.

‘Our goal has been to choose solutions that are genuinely sustainable and improve energy efficiency in the new hospital, but are operationally secure at the same time. For example, the energy costs of the new hospital are aimed at savings of about 30–40% compared to the old hospital,’ says Program Director Kari-Pekka Tampio.

The new hospital will have a smaller overall area, but will be more efficient in its use of space. Space will be sufficient when operations are planned in a new manner. User oriented planning has played a key role in this: hospital staff have participated in the design of their own future operations and facilities.

Flexibility and convertibility have also been a key criterion. Spaces and equipment will also become more jointly used. New digital solutions contribute to reducing the hospital's carbon footprint. In the future, remote medical services and other digital service channels will enable the hospital's patients to not only have a pleasant but also ecological alternative to engage with the hospital.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Miia Turpeinen, Director of the University Hospital, miia.turpeinen@pohde.fi, +385 40 152 2655

Kari-Pekka Tampio, Programme Director, kari-pekka.tampio@pohde.fi, +385 40 151 4005

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Grid Dynamics Announces AI-Powered Engagement Model Enabling Accelerated Business Transformation for Fortune 1000 Enterprises23.6.2025 16:15:00 EEST | Press release

Grid Dynamics Holdings, Inc. (Nasdaq: GDYN) (Grid Dynamics)—a prominent technology consulting and digital services provider specializing in AI, platform and product engineering, and digital engagement services—today announced the launch of an innovative AI-powered engagement model for its software engineering services. This new model is specifically engineered to deliver the next level of agility, quality, and accelerated time-to-market for Fortune 1000 enterprises. Grid Dynamics' innovative approach expands its engagement offerings beyond traditional Fixed Price, Time and Materials, and Capacity-based engagements. Key features include: Prompt-driven incremental output: Delivering value through iterative, prompt-guided development. Credit-based service consumption: Pricing aligned with desired outputs rather than effort—offering cost efficiency. AI-benchmarked code quality: Continuous evaluation against industry and client standards—ensuring code quality. Centralized client portal: A s

Live Biotherapeutics at a Crossroad: Novotech White Paper Outlines Opportunities and Early-Stage Challenges23.6.2025 15:05:00 EEST | Press release

As Live Biotherapeutic Products (LBPs) begin to transition from frontier science to clinical reality, Novotech, a leading global CRO and scientific advisory partner has published a new white paper examining the opportunities and challenges shaping this fast-evolving landscape of therapeutic class. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250623205345/en/ LBPs, which harness live microorganisms to restore or modulate human health, are being explored across a growing range of indications, from gastrointestinal and metabolic disorders to CNS and oncology. FDA approvals of Rebyota™ and Vowst™ have validated the category but for most biotech sponsors, the journey remains uncertain. According to Novotech’s analysis, over 90% of LBP assets are still in early development stages, and nearly one-third of all trials from 2020 to 2025 have been withdrawn or suspended due to regulatory, manufacturing, or design complexities. Highli

Sagemcom’s Net Zero Trajectory Approved by SBTi: Target Set for 204023.6.2025 15:00:00 EEST | Press release

Sagemcom Group has today reached a critical milestone in its climate strategy: its Net Zero carbon target for 2040—encompassing all activities and sites within the Group’s consolidated scope—has been officially validated by the Science Based Targets initiative (SBTi). This international endorsement attests to the scientific rigor of Sagemcom’s decarbonization strategy, aligned with the Paris Agreement’s ambition to limit global warming to 1.5°C. It strengthens the Group’s comprehensive climate roadmap, which is built on a significant reduction of greenhouse gas emissions across all scopes: By 2030: A 47% absolute reduction in Scope 1 and Scope 2 emissions (direct emissions and purchased energy), 100% renewable energy consumption across all Group sites, A 31% absolute reduction in Scope 3 emissions, including those related to the value chain, with no exclusion of any greenhouse gas categories. By 2040: Achievement of Net Zero, corresponding to a 90% absolute reduction in total Group emi

One, Two, Three-Peat: Mary Kay Inc. Named #1 Direct Selling Brand of Skin Care and Color Cosmetics in the World for Three Years in a Row23.6.2025 15:00:00 EEST | Press release

Good things come in threes: iconic beauty brand and global entrepreneurship company Mary Kay Inc. has again been named the #1 Direct Selling Brand of Skin Care and Color Cosmetics in the World1 by Euromonitor International for the third consecutive year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250623000452/en/ Ryan Rogers, Chief Executive Officer of Mary Kay states: "Being named the #1 Direct Selling Brand of Skin Care and Color Cosmetics in the World by Euromonitor International three years in a row marks a grand slam achievement for Mary Kay. This repeated milestone reflects years of R&D and marketing efforts to create skin and beauty solutions that meet consumer needs and are loved the world-over. Above all, it demonstrates the transformative power of our Independent Beauty Consultants who are driving this success globally." (Photo Courtesy: Mary Kay Inc.) Euromonitor International is the foremost provider of globa

Fujirebio Acquires Plasma Services Group and Strengthens Its Position as Provider of Critical and High Quality Biological Raw Materials to the IVD and Life Science Industries23.6.2025 14:00:00 EEST | Press release

H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio Holdings, Inc. (hereinafter “Fujirebio”) today announced that Fujirebio Diagnostics, Inc., a subsidiary of Fujirebio, has acquired all shares of Plasma Services Group, Inc. (hereinafter “Plasma Services Group”). The transaction value has not been disclosed. Founded in 2004, Plasma Services Group has specialized in the collection, screening and supply of high quality and rare biological materials required for R&D and manufacturing in the in vitro diagnostics (IVD) and life science industries. The company is particularly well positioned in the field of rare diseases. From its state-of-the-art FDA registered, ISO certified facility in Moorestown, NJ, USA, Plasma Services Group provides sera and other samples for materials of control reagents and calibrators for a wide range of diseases and offers sample collection services globally. For more information about Plasma Services Group please visit www.plasmaservicesgroup.com

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye